Introduction: To review how changes in data storage and analysis can impact quality and quality
| INTRODUCTION
Quality in cytology is most often measured using standard quality assessment measures. As a result, quality assessment is an integral part of every cytology laboratory. Quality assessment in cytology takes many different forms, but all of these quality assessment methods rely on data that is collected and stored in the cytology laboratory and the methods used to analyze this data. Most current laboratory information systems (LISs) have built in components designed to facilitate these quality assessment methods, but these components are typically "hard wired" and difficult to modify or improve. Potential ways to improve quality assessment methods that rely on modifying these components have already been proposed 1 but have not been
adopted. This review focuses on ways to improve cytology by improving the way in which data is stored, accessed, and analyzed to allow cytologists to take advantage of modern statistical tools.
| CURRENT PRACTICE
At present the majority of cytology laboratories perform quality assessment in cytology along the lines proposed by the College of American Pathologists (CAP), 2 see Table 1 . These quality measures are derived from a relatively small number of "core" parameters, most
but not all of which are routinely captured in current LISs (see Table 2 ). For example, a common measure, turnaround time, is derived from the core parameters of accession time and signout time. While some of these measures are related to each other, for the most part each quality measure is dealt with separately and independently from all the others. As a result, in an un-automated laboratory, each measure may be tracked by an individual, separate log. In automated laboratories, each measure is tracked by a separate dedicated function within the LIS.
Within either of these frameworks (hand written logs or dedicated reports from the LIS), some authors have looked to the clinical laboratory for ways to improve the utility of this data. 3 A common approach is to separate preanalytic, analytic, and postanalytic processes and to use variants of Levey-Jennings plots to continuously document performance that is within and outside of acceptable ranges. This approach has already been shown to lead to some success, in particular with clinicians who are providing suboptimal specimens. However, there are several limitations that remain with this approach.
Perhaps the most important limitation is statistical power. While many laboratories see a large number of gynecologic cytology specimens, most laboratories see far fewer nongynecologic cytology specimens, and these nongynecologic cytology specimens are from a wide variety of sites. As a result, it can be difficult to review enough of any particular type of case to identify statistical meaningful trends unless one uses a very long time frame. Prospective studies may take years to accomplish. 4 While the results of such studies can significantly improve the cytologic process, this is not the time frame that most cytology laboratories use to perform quality assessment.
Second, the most common target that is successfully improved with current cytologic quality assessment is preanalytic error. The classic example is identifying the clinician who submits more suboptimal specimens than his or her colleagues. In both the literature and our own experience, cytologic quality assessment has been far less successful at improving the interpretive performance of cytologists. In most settings sensitivity and specificity are trade-offs, so while it is easy to identify that an individual or a particular setting has a lower or higher threshold for a particular diagnosis, 5, 6 it is much more difficult to be sure which diagnostic threshold is better. mitted to pathology, in the ideal system the diagnostic imaging study would be one or two clicks away for the pathologist when he or she is preparing the cytology report, and after the report is issued, it should be automatically tabulated with the imaging report to streamline the quality assurance workflow for the radiologist.
Sixth, while most LISs will allow the user to create a list of cases using a free text search, most LISs will not allow the direct creation of a separate relational database, even though the LIS itself is usually a relational database. Such a relational database can also be created from hierarchical databases, although the process may more complex.
If, for example, one wants to create a database of all thyroid fine needle aspirations with an indeterminate diagnosis, one will have to perform a text based search to identify cases, and then one will have to manually extract the other elements one desires in a database (age, sex, location, etc.) from the LIS. For the most part, every cytology 
| HOW DATA IS HANDLED IN OTHER SETTINGS
One of the hottest topics today is big data. 9 Many users, including large corporations and enterprises, are using the computational power of modern day information systems to gain insights into their own processes and their customers' needs. This revolution is also taking place in the area of bioinformatics and next generation sequencing.
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While the individual features vary from setting to setting, there are some features of this process that are common to all these settings. In particular, in order to take advantage of their data the companies are spending the time and effort to ensure that:
1. The data is at least semi-structured;
2. All the data is captured;
3. The data can be imported and exported easily from the storage platform;
4. The data is separate from the analytic platform.
Most often the extracted data is stored in either a relational database such as SQL, a data file (such as a CSV or Excel file) with every case representing a row and every variable a column, or less commonly a nonrelational database. The choice depends on both the size of the database and the relationship between the variables of interest.
Most of the analytical tools can work with any of these formats. With the data of interest in hand, the corporation has a variety of different analytic tools available to examine this data. Data analysis can be done with a generic programing package such as Python, 11 a dedicated statistical programming package such as R, 12 or with a wide variety of less common analytical tools. Depending on the size of the data set, the analysis can be done on a single machine or multiple machines using a variety of parallel processing methods such as Apache 
| IMPROVING THE LABORATORY INFORMATION SYSTEM
Cytology LISs were created in an era when the LIS had to stand alone.
As a result, they had to do everything, including data storage and data analysis. While most current LISs do use a relational database to store their data, they are not designed to allow that data to be accessed except in very specific ways using very specific tools. In addition,
because the methods used to analyze the data were limited, the number of items that needed to be structured and accessed on their own was also limited. There was no problem with allowing the diagnosis to available to analyze such a data set. To make current LISs more useful, cytologists must push for both more structured data and the ability to access or create databases that can be evaluated outside the LIS itself.
| STRUCTURED DATA
Many sophisticated text search techniques, including natural language parsers have been developed to mine free text data such as cytology reports. 15 In essence these techniques attempt to find the underlying structure in the data and then extract the data according to that structure. Templated reports and standardized terminology facilitate natural language processing, but this is not the best or only approach to analyzing cytology data. An alternative approach is to format and store this data as structured data at the time of diagnosis, thus avoiding the need to search for the underlying structure. The College of American Pathologists Pathology Electronic Reporting Committee (PERT) has developed and promulgated electronic cancer case summaries (eCCs) which are based on the paper cancer case summaries that are available on the CAP website. 16 The eCCs enable capture of the pathology information as structured data using consistent terminology, greatly facilitating searching, sorting, and mining of the data in these reports. There is significant variation in the way in which pathologic information is currently reported. One study of breast excisions 15 found that there were 124 ways of saying "invasive ductal carcinoma" was present, and over 4000 different ways of saying that invasive ductal carcinoma was not present. This suggests that efforts to structure data and reduce variability will likely be much more efficient than relying on natural language parsers to identify information of interest.
Nevertheless, implementing structured reporting is a delicate task that must proceed slowly and cautiously. Nothing is more personal to a cytologist than the specific words they use in a cytology report, and forcing cytologists to use phrases they do not feel are acceptable can only create resistance. In addition, unintended side effects of structured data creation have already been demonstrated that may result in decreased quality if not appropriately compensated for Ref. 17 . In particular, creating structured data in a pathology report appears to be more work and may be associated with increased error unless methods are employed to facilitate the structured data creation. 18 The process of creating methods to aid in the creation of structured data sets will likely be an iterative process that will require several rounds to achieve all of its goals.
Nevertheless, structured data sets already exist in medicine.
There are computer methods to analyze and track Operating Room reports, cancer patients, ER physician reports, and results in the clinical laboratory. 19, 20 The CAP checklists for reporting the essential data elements in tumors are text based, but have been largely converted into fully structured electronic data sets which are mostly deployed within commercial laboratory information systems and which most pathologists are familiar with. And of course, The Bethesda Systems of nomenclature for reporting Gynecologic Cytology, Lower Anogenital Tract, and Thyroid Cytology are ready-made for structured data. [21] [22] [23] These structured data may be easier for physicians and their extenders to consistently use and understand. 24 There are several different ways to implement structured data sets in cytology. One method is to incorporate it into the LIS itself.
However, the success of this approach relies on the willingness of the vendor to build it. The experience of the CAP PERT committee is that different vendors have widely different interest levels in working on this project. Alternatively, semi -structured data entry methods can be deployed using the internet. 18 These methods allow the users to have access to data entry methods and content that is updated in real time.
It is likely that both methods have a place in the future of cytology. Table 2 are from database fields which may contain multiple parameters, such as ancillary studies, or specimen quality indicators. In the quality assurance database that we envision, one can easily extract any desired combination of entries, for example; HSIL from the interpretation field and low specimen cellularity from adequacy field, or any desired combination of immunohistochemical results if the stains have been ordered (eg, negative TTF-1 with positive cytokeratin 7 on aspirates of lung masses). We also envision the ability to quickly aggregate data to meet all CAP accreditation requirements, such as determining the estrogen receptor negative rate without laborious manual counting of results from purely text-based, unstructured reports.
| CONCLUSION
With easy access to highly structured datasets that contain not just the results but the core parameters and previous quality assurance data as well, cytologists could then make use of the many analytical tools that are freely available on open source platforms to investigate their data more thoroughly. They could also more easily collaborate with cytologists at other laboratories to create meaningful larger data sets that would allow statistically powered analysis of their performance in a time frame that is appropriate for quality assessment methods. These datasets could then be used to identify new and useful quality assessment methods that can lead to measureable improvement in the performance of cytology. One of the keys to making cytology a vibrant and cutting edge discipline even in the genomic era is more sophisticated quality assessment tools that can only come from working together to create larger, more powerful datasets that can be analyzed with modern day tools.
